Active, Not Recruiting
Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation - CV185-286
Updated: 28 January, 2019 | ClinicalTrials.gov
Print Friendly Summary
Trial Details
Gender(s)
Age Range
Active, Not Recruiting
Treatment Options
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com. Inclusion Criteria: - Patients who are beginning to receive the treatment with this product under the approved indications, dosage, and administration will be included in this study Exclusion Criteria: - Patients who are receiving Eliquis outside of its approved indication will be excluded from this study
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information